Significant improvement in the understanding of mesenchymal stem cell (MSC) biology has opened the way to their clinical use. However, concerns regarding the possibility that MSCs undergo malignant transformation have been raised.
Summary
Significant improvement in the understanding of mesenchymal stem cell (MSC) biology has opened the way to their clinical use. However, concerns regarding the possibility that MSCs undergo malignant transformation have been raised.
We investigated the susceptibility to transformation of human bone marrow (BM)-derived MSCs at different in vitro culture time points. MSCs were isolated from BM of 10 healthy donors and propagated in vitro until reaching either senescence or passage (P) 25 . MSCs in the senescence phase were closely monitored for [8] [9] [10] [11] [12] weeks before interrupting the cultures. The genetic characterization of MSCs was investigated through array-comparative genomic hybridization (array-CGH), conventional karyotyping and subtelomeric fluorescent in situ hybridization (FISH) analysis both before and after prolonged culture. MSCs were tested for the expression of telomerase activity, hTERT transcripts and alternative lengthening of telomere (ALT) mechanism at different passages. A huge variability in terms of proliferative capacity and MSCs life-span was noted between donors. In eight of ten donors, MSCs displayed a progressive decrease in proliferative capacity until reaching senescence. In the remaining two MSC samples, the cultures were interrupted at P25 to pursue data analysis. Array-CGH and cytogenetic analyses demonstrated that MSCs expanded in vitro did not document chromosomal abnormalities.
Telomerase activity and hTERT transcripts were not expressed in any of the examined cultures and telomeres shortened during the culture period. ALT was not evidenced in the MSCs tested. BM-derived MSCs can be safely expanded in vitro and are not susceptible to malignant transformation, thus rendering these cells suitable for cell-therapy approaches.
Introduction
In recent years, a significant improvement in the understanding of multipotent mesenchymal stromal cell (MSC) biology 1 has opened the way to the clinical use of these adult stem cells. MSCs have been employed in several approaches for reparative/regenerative cell therapy, as well as in the perspective of modulating immune response against alloantigens. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] MSCs have the ability to differentiate into multiple lineages, such as osteoblasts, tenocytes, adipocytes and chondrocytes [14] [15] [16] and may be identified by both their capacity to adhere to plastic and their phenotypic characterization through a panel of cell surface molecules including CD90, CD105 and CD13.
However, a unique and specific MSC marker, which would allow their exclusive identification, has not yet been found.
The large interest in MSC applicability for clinical approaches relies on the ease of their isolation from several human tissues such as bone marrow (BM), adipose tissue, placenta and amniotic fluid [17] [18] [19] , on their extensive capacity for in vitro expansion and on their functional plasticity.
Concerns that adult human MSCs may be prone to malignant transformation have been recently raised. In fact, human adipose tissue-derived MSCs have been shown to undergo spontaneous transformation after long-term in vitro culture. 20 The same phenomenon was also noted in murine BM-derived MSCs 21 , which, after numerous passages in culture, increased telomerase activity and proceeded to malignant transformation. A previously published study 22 has also documented that murine gastric epithelial cancer originates from BM-derived cells, presumably MSCs, after recruitment of these cells to the chronically injured mucosal site.
The use of MSCs for clinical approaches in many fields of medicine first requires that the bio-safety of these cells be carefully investigated through appropriate and sensitive tests. Indeed, the absence of transformation potential in cultured MSC has to be documented before considering infusion of these cells into patients, particularly into immune-compromised subjects where failure of immune surveillance mechanisms might further favor the development of tumors in vivo.
The aim of this study was to investigate the potential susceptibility of human BM-derived MSC to malignant transformation at different in vitro culture time points and to ascertain whether the biological properties of these cells after ex vivo expansion remain appropriate for cell therapy approaches. 
Materials and methods

Multilineage differentiation potential of MSCs
To assess their differentiation capacity, MSCs cultured from all BM donors were induced into adipocytes and osteoblasts at P3, P6 and at later passages whenever possible, employing a method previously described. 23, 24 To detect osteogenic differentiation, cells were stained for alkaline phosphatase Primers for the internal ȕ-actin control were added during cycle 15 at 72°C.
Amplified products were electrophoresed on a 5% non-denaturing polyacrylamide gel in 1X Tris-borate EDTA buffer. The gel was dried and autoradiographed.
Detection of alternative lengthening of telomere (ALT)-associated promyelocytic leukemia (PML) bodies (APBs)
Cells were fixed in 1:1 methanol:acetone and processed to detect APBs by combined PML immunofluorescence and telomere FISH according to Henson et al. 26 Images were captured on a Nikon Eclipse E600 fluorescence microscope using ACT-1 (Nikon, Tokyo, Japan) image analysis software and processed using Adobe Photoshop Image Reader 7.0 software. APB status was determined according to previously defined criteria. The presence of an APB was defined by the localization of a telomeric DNA focus within a nuclear PML body;
samples were scored as APB-positive if they contained APBs in 0.5% of cells.
To avoid false positives, an APB was considered to be present only when the telomeric DNA fluorescence within a PML body was more intense than that of telomeres, and a cell was not considered to contain APBs if >25% of the colocalized foci occurred outside the nucleus. To avoid false negatives, at least 2,000 nuclei were examined, and the assay was repeated in the presence of Samples were classified as ALT-positive when 2/3 or 3/3 of these criteria were met for unimodal or bimodal TRF length distributions, respectively. 26 Statistical analysis of TRF length distributions was performed using the Telometric software. 
Results
Characterization of human BM-derived MSCs during long term in vitro culture
MSCs derived from BM of the 10 healthy donors were isolated and propagated in long term in vitro culture. MSCs from all donors were characterized by morphology, differentiation capacity and immune phenotype at different culture time points, namely P3, P6, P9, P12, P15 and later, whenever possible, every 2-3 passages ( Figure 1A , 1B, 1C and 1D). Since array-CGH is not able to unravel balanced chromosomal rearrangements, classical cytogenetics with conventional QFQ banding and FISH analysis with chromosome subtelomeric-specific probes were performed on chromosome metaphases obtained from MSCs at variable passages in culture (P2-11), in order to detect reciprocal translocations. Karyotyping was performed in all donors: only one out of the ten MSC samples was characterized by a pericentric inversion of chromosome 9, which represents a well-known variant without any phenotypic effect. Therefore, all MSC donors were characterized by a normal karyotype ( Figure 6A ). FISH analysis with chromosome subtelomeric-specific probes was performed on chromosome methaphase of three donors (two at T 1 and one at T 2 , Figure 6B ) and resulted normal in all cases. 
Discussion
In the present study, we have generated, propagated in long term in vitro culture and monitored human MSCs derived from 10 BM donors. Importantly, BM represents the source of MSCs most commonly used in cell-therapy approaches.
MSCs from all donors were characterized, at several culture time points, on the cell/well in a 96-well plate failed; this cell behavior is very different from that described by Wang et al. 35 on a subpopulation of human MSCs derived from one single BM sample (named 'huBM020') that showed very rapid population doubling and could be easily cloned in a single-cell assay. Post-senescence
MSCs were analyzed by flow-cytometry and showed the typical MSC markers at high levels (including CD90 and CD105), whereas they were negative for hematopoietic markers (CD45, CD34) and for CD133 and VEGFR2. On the contrary, the transformed cells described by Wang and colleagues 35 were shown to express the endothelial markers CD133 and VEGFR2, as well as low levels of CD90, and they were CD105 negative. The same down-regulation of the MSC membrane markers CD90 and CD105 was noted in the post-crisis cells described by Rubio et al 20 , which were derived from adipose tissue.
Furthermore, the TRAP assay performed on post-senescence MSCs derived from donor N.1 failed to exhibit the expression of telomerase catalytic activity.
All these findings demonstrate that our post-senescence cells are not different from normal MSCs, since they display the same particular MSC characterization parameters.
Regarding morphology, we noticed that MSCs from four donors (#3-5-6-7)
became smaller in size when cultured over P13-15, although they maintained the typical spindle shape and a constant, growth rate ( Figure 1A, right) . On the contrary, the cells described by both Wang and Rubio 35, 20 resulted in cells morphologically distinct from typical MSCs; they were round or cuboidal, and, in the paper published by Wang and colleagues 35 , also exhibited contactindependent growth and formed foci with cells released into suspension. In our study MSCs from all ten donors, tested both at early (P3, infusion passage) and late passages (P9-25) did not show immune phenotypic abnormalities and maintained a high level of purity throughout the culture period ( Figure 1D ).
Moreover, all cultures exceeding P10 were analyzed for the expression of CD133 and VEGFR2 and resulted negative. Also the ability to differentiate into osteoblasts and adipocytes was preserved throughout the culture period in all MSC donors ( Figure 1B and 1C ).
In agreement with previous reports 36 , all our MSC samples lack expression of telomerase activity both at early passages and after long term in vitro culture (up to P24 
